Focused Spinal Stenosis Rehabilitation Program for Lumbar Spinal Stenosis

February 1, 2018 updated by: Hospital for Special Surgery, New York

Focused Spinal Stenosis Rehabilitation Program vs. Generic Williams Flexion Protocol

Lumbar spinal stenosis with neurogenic claudication is a common condition in the elderly population and is characterized by bilateral buttock, thigh, or calf discomfort and/or pain, as well as by weakness precipitated by walking and prolonged standing. Self-management options include physical therapy, which includes exercise as a core component for improving the flexibility and mobility of the spine and hips. A Williams flexion protocol has historically been used to treat low-back pain following degenerative changes to the posterior elements of the lumbar spine. However, few studies have been done to validate the efficacy of this protocol. A more focused treatment protocol may be more efficacious. Patients in this study will be randomized to receive either the generic physical therapy protocol (15 sessions) or the focused rehabilitation program (5 sessions). The sessions will take place over the course of 6 months. Outcomes will be assessed using validated questionnaires and physical function tests.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10021
        • Hospital for Special Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Lumbar spinal stenosis with neurogenic claudication
  • Symptoms present for at least 3 months
  • Moderate to severe acquired or congenital LSS based on radiological evaluation
  • Lumbar MRI obtained within the past 12 months prior to initial physical therapy visit
  • 40 years of age or older
  • Body mass index less than or equal to 35
  • Can tolerate a 6-min treadmill test
  • Willing to comply with home exercises as prescribed

Exclusion Criteria:

  • Acute disc herniation
  • Grade 3 or greater spondylolisthesis
  • Rheumatoid or autoimmune conditions (e.g., ankylosing spondylitis)
  • Active spinal compression fractures
  • Knee surgery in the previous 6 months (e.g., total knee arthroplasty)
  • Previous spinal fusion
  • Absence of pedal pulses
  • Inflammation/infectious process
  • Myelopathy
  • Psychiatric disorder preventing informed consent or participation in assigned physical therapy sessions
  • Patients with pending litigation or workers compensation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard
The Williams flexion protocol group will participate in 15 treatment sessions.
Experimental: Individualized
The focused spinal stenosis rehabilitation group will participate in 5 treatment sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional ability
Time Frame: Up to 1 year after initial physical therapy visit
Change in functional ability will be assessed using the Oswestry Disability Index. The minimum clinically important difference of the ODI has been documented in the literature as a 13-point change.
Up to 1 year after initial physical therapy visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: Up to 1 year after initial physical therapy visit
Pain will be measured by the Numerical Pain Rating Scale, on a 0-10 scale, where 0=no pain and 10=worst pain.
Up to 1 year after initial physical therapy visit
Quality of life
Time Frame: Up to 1 year after initial physical therapy visit
Quality of life will be measured using the PROMIS Physical Function 10a Questionnaire.
Up to 1 year after initial physical therapy visit
Tolerance to exercise
Time Frame: Up to 1 year after initial physical therapy visit
The Timed Treadmill Test, which requires patients to walk on a treadmill at 1.2 miles per hour and a 1% grade and report when they begin experiencing typical exercise-induced symptoms, will be used.
Up to 1 year after initial physical therapy visit
Physical ability
Time Frame: Up to 1 year after initial physical therapy visit
Physical ability will be assessed upon exams that measure balance, hip abductor strength, range of motion, etc.
Up to 1 year after initial physical therapy visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Robert Turner, Hospital for Special Surgery, New York

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Actual)

February 1, 2018

Study Completion (Actual)

February 1, 2018

Study Registration Dates

First Submitted

December 1, 2016

First Submitted That Met QC Criteria

December 1, 2016

First Posted (Estimate)

December 5, 2016

Study Record Updates

Last Update Posted (Actual)

February 5, 2018

Last Update Submitted That Met QC Criteria

February 1, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Stenosis Lumbar

Clinical Trials on Williams flexion protocol

3
Subscribe